Skip to main content

Table 3 Multivariate regression analysis of pulsatility with the risk of endobronchial biopsy-induced hemorrhage

From: Association between blood pressure and the risk of biopsy-induced endobronchial hemorrhage during bronchoscopy

Pulsatility

n

Odds ratio (95% CI)

 

Non-adjusted

Adjusted*

Pulse pressure (mmHg)

   

 Q1 (6-41)

157

1.0

1.0

 Q2 (42-51)

149

0.807 (0.510, 1.277)

0.770 (0.469, 1.265)

 Q3 (52-62)

173

0.915 (0.590, 1.419)

0.932 (0.570, 1.524)

 Q4 (63-105)

164

0.658 (0.417, 1.038)

0.606 (0.361, 1.017)

 P for trend

 

0.113

0.101

 Continuous, per 10 mmHg

 

0.987 (0.977, 0.998)

0.986 (0.974, 0.997)

PP/DP

   

 Q1 (0.07-0.52)

160

1.0

1.0

 Q2 (0.53-0.66)

161

0.653 (0.417, 1.023)

0.652 (0.400, 1.064)

 Q3 (0.67-0.83)

161

0.727 (0.466, 1.135)

0.729 (0.445, 1.193)

 Q4 (0.84-1.74)

161

0.569 (0.361, 0.895)

0.533 (0.319, 0.891)

 P for trend

 

0.028

0.029

**Continuous, per SD

 

0.810 (0.685, 0.956)

0.788 (0.653, 0.951)

  1. *Adjusted for age, gender, BMI, smoking, lesion locations, cancer histological type and stage, PT, APTT, triglycerides, HDL-C, WBC, platelets, and CRP
  2. BMI, body mass index; PT, prothrombin time; APTT, activated partial thromboplastin time; HDL-C, high-density lipoprotein cholesterol; WBC, white blood cell; CRP, C-reactive protein; PP, pulse pressure; DP, diastolic pressure; SD, standard deviation
  3. **1 SD=0.24 PP/DP
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us